Replies to post #411462 on Anavex Life Sciences Corp (AVXL)

[Pazzo1212]

There’s the million dollar question.

[kund]

TGD is waiting for zumba class to over, he need to get in shape before he meet FDA, he want to look classy may be next 007

[abew4me]

If this post is correct, then it explains why Anavex hasn't filed for the NDA because they're still accumulating information...and it also explains why they took down all of the the slide decks for the P2b/3 trial...again, they're still accumulating new information. (See the post below)

hnbadger
Friday, February 17, 2023
Post# of 404558

This is from AVXL IR:
The company is working on another
video and an upcoming press release
that will address many of the
questions that you asked. Moreover,
some of the answers will elaborate
on specifics, all of which we believe
will provide a thorough
understanding of our initiatives. At
this time some of your questions can
not be answered today, because new,
updated data will be available to us
in the near future, all of which we
would need to disseminate such
information in accordance with
Regulation FD - via press releases
and/or 8k filing, not through an
individual email or one-on-one
conversation.
Thanks 100fold from ST

[kevindenver]

I believe that question was answered. Focus on the dismal historical track record, and "the unknown" for your dark sarcasm. It keeps me entertained while I wait. I hear it just around the corner.

"As far as next steps go, we are expecting full comprehensive results of the entire AD 2b/3 trial, which will be presented via paper or otherwise. After of course, we look forward to speaking with the FDA, EMA, TGA, and other global regulators. We believe our biomarker suite is compelling for approval."

Ok. So with all endpoints of the P2b/3 AD trial met, then what is Missling waiting for then before speaking to FDA et. al?

[Steady_T]

Maybe Missling wants to have ALL the data before meeting with the FDA.

So with all endpoints of the P2b/3 AD trial met, then what is Missling waiting for then before speaking to FDA et. al?